With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

Dupilumab vs placebo was linked to improved health-related quality of life and respiratory symptoms in patients with COPD and T2 inflammation.

Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased ...

chronic obstructive pulmonary disease (COPD), and patients who have received a lung transplant. It ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

Breathing is a fundamental aspect of life, yet many individuals struggle with respiratory health issues that significantly ...

Regardless of what's causing the condition, COPD is treatable. "The mainstays of therapy have historically been inhaled bronchodilators and inhaled steroids," says Han. Such medications can reduce ...